Hajyasini A, Dehnad A, Farzi A, Mobasseri M, Ostadrahimi A, Kafili B
Higher education institute of Rab-Rashid, Tabriz, Iran.
Department of Bacterial Diseases Research, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Arch Razi Inst. 2025 Feb 1;80(1):257-261. doi: 10.32592/ARI.2025.80.1.257. eCollection 2025 Feb.
Selenium (Se) is a trace mineral that plays a critical role in public health. It is a vital component of numerous enzymes and proteins called selenoproteins, thus affecting a wide range of biological activities. Hashimoto's disease is the most common cause of hypothyroidism. In addition to being a critical micronutrient for thyroid health, selenium has a direct association with liver health. The objective of this study is to examine the impact of Selenium on lipid factors, thyroid factors (anti-TPO and TSH), and liver enzymes. A double-blind, randomized clinical trial was conducted, enrolling 40 patients with Hashimoto's thyroiditis in two equal control (placebo) and intervention (Selenium) groups. Participants received 200 micrograms of Selenium over 60 days, with blood samples collected before and after the intervention. The spectrophotometric method was employed to measure total blood catalase, anti-TPO, TSH, malondialdehyde, serum lipid profile, and liver factors. The results were then subjected to statistical analysis. The study revealed a significant decrease in plasma MDA levels in response to selenium consumption. Additionally, a notable increase in hemoglobin levels was observed in the experimental group following the intervention, reaching a statistical significance of P<0.05. However, catalase enzyme, lipid profile components, and liver enzymes in the intervention group remained largely unchanged compared to the pre-intervention and control groups (P>0.05).TSH and anti-TPO levels exhibited a relative decrease in the intervention group (P>0.05). The findings of this study suggest a potential association between selenium consumption and improved serum lipid factors, liver enzymes, anti-thyroid peroxidase antibody, MDA, and HGB levels in individuals diagnosed with Hashimoto's thyroiditis.
硒(Se)是一种在公共卫生中发挥关键作用的微量元素。它是众多被称为硒蛋白的酶和蛋白质的重要组成部分,从而影响广泛的生物学活动。桥本氏病是甲状腺功能减退最常见的原因。除了是甲状腺健康的关键微量营养素外,硒还与肝脏健康直接相关。本研究的目的是研究硒对脂质因子、甲状腺因子(抗甲状腺过氧化物酶和促甲状腺激素)和肝酶的影响。进行了一项双盲随机临床试验,将40例桥本氏甲状腺炎患者分为两个相等的对照组(安慰剂组)和干预组(硒组)。参与者在60天内服用200微克硒,并在干预前后采集血样。采用分光光度法测量全血过氧化氢酶、抗甲状腺过氧化物酶、促甲状腺激素、丙二醛、血脂谱和肝脏因子。然后对结果进行统计分析。研究发现,摄入硒后血浆丙二醛水平显著降低。此外,干预后实验组血红蛋白水平显著升高,达到P<0.05的统计学显著性。然而,与干预前和对照组相比,干预组的过氧化氢酶、血脂谱成分和肝酶基本保持不变(P>0.05)。干预组促甲状腺激素和抗甲状腺过氧化物酶水平相对降低(P>0.05)。本研究结果表明,摄入硒与改善桥本氏甲状腺炎患者的血清脂质因子、肝酶、抗甲状腺过氧化物酶抗体、丙二醛和血红蛋白水平之间可能存在关联。